CREBBP and cancer: The proliferation pathways of cancer cells that can be inhibited by artemisinin include adenosine monophosphate (AMP), Wnt beta signalling pathway (Wnt/Beta) catenin, and second messengers involved in intracellular signalling (nuclear factor kappa-light-chain-enhancer of activated B cells (NF κB), CREB binding protein (CREBBP), MYC, angiogenesis factors, as well as mechanistic target of rapamycin (mTOR) [28].